• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Morrissey Michael J. converted options into 2,779 shares, increasing direct ownership by 376% to 3,519 units (SEC Form 4)

    5/9/25 4:05:20 PM ET
    $SKWD
    Property-Casualty Insurers
    Finance
    Get the next $SKWD alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Morrissey Michael J.

    (Last) (First) (Middle)
    800 GESSNER ROAD
    SUITE 600

    (Street)
    HOUSTON TX 77024

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Skyward Specialty Insurance Group, Inc. [ SKWD ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/07/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/09/2025 M 2,779 A (1) 3,519 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    2025 RSU Award (2) 05/07/2025 A 1,797 (3)(4) (3)(4) Common Stock 1,797 $0 1,797 D
    2024 RSU Award (2) 05/09/2025 M 2,779 (5) (5) Common Stock 2,779 $0 0 D
    Explanation of Responses:
    1. Each Restricted Stock Unit ("RSU") settles for one share of the Issuer's Common Stock.
    2. Each RSU represents the right to receive, at settlement, one share of Common Stock of the Issuer.
    3. On May 7, 2025, the Reporting Person was granted an RSU Award in the amount of 1,797 RSUs. Subject to the terms of the award agreement, this award will fully vest on May 7, 2026.
    4. The Reporting Person has elected to defer the settlement of this RSU award until their separation from the Company, pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors.
    5. On May 9, 2024, the Reporting Person was granted an RSU Award in the amount of 2,779 RSUs. Subject to the terms of the RSU Agreement, this award fully vested on May 9, 2025.
    /s/ Stacy E. Skelton, Attorney-in-Fact 05/09/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SKWD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SKWD

    DatePrice TargetRatingAnalyst
    4/11/2025$59.00Buy → Hold
    Jefferies
    3/14/2025$53.00 → $63.00Equal Weight → Overweight
    Barclays
    2/28/2025Outperform → Peer Perform
    Wolfe Research
    1/13/2025$43.00Hold
    TD Cowen
    9/5/2024$44.00Equal Weight
    Barclays
    8/19/2024Outperform
    William Blair
    7/12/2024Outperform
    Oppenheimer
    1/11/2024$39.00Outperform
    Wolfe Research
    More analyst ratings

    $SKWD
    SEC Filings

    See more
    • SEC Form 144 filed by Skyward Specialty Insurance Group Inc.

      144 - Skyward Specialty Insurance Group, Inc. (0001519449) (Subject)

      6/13/25 10:19:16 AM ET
      $SKWD
      Property-Casualty Insurers
      Finance
    • SEC Form 144 filed by Skyward Specialty Insurance Group Inc.

      144 - Skyward Specialty Insurance Group, Inc. (0001519449) (Subject)

      6/6/25 5:37:46 PM ET
      $SKWD
      Property-Casualty Insurers
      Finance
    • Skyward Specialty Insurance Group Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders

      8-K - Skyward Specialty Insurance Group, Inc. (0001519449) (Filer)

      5/13/25 4:17:47 PM ET
      $SKWD
      Property-Casualty Insurers
      Finance

    $SKWD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kuczinski Anthony J bought $14,468 worth of shares (400 units at $36.17), increasing direct ownership by 11% to 4,124 units (SEC Form 4)

      4 - Skyward Specialty Insurance Group, Inc. (0001519449) (Issuer)

      3/5/24 4:23:01 PM ET
      $SKWD
      Property-Casualty Insurers
      Finance